BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 29626453)

  • 1. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
    Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
    ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy.
    Bonde P; Ku NC; Genovese EA; Bermudez CA; Bhama JK; Ciarleglio MM; Cong X; Teuteberg JJ; Kormos RL
    Ann Thorac Surg; 2012 May; 93(5):1541-7; discussion 1547-8. PubMed ID: 22480391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle.
    Kawabori M; Kurihara C; Sugiura T; Cohn WE; Civitello AB; Frazier OH; Morgan JA
    Ann Thorac Surg; 2018 Mar; 105(3):799-806. PubMed ID: 29290308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Models for End-Stage Liver Disease Score in Patients With Pulsatile Flow POLVAD MEV Left Ventricular Assist Device Support.
    Nadziakiewicz P; Szyguła-Jurkiewicz B; Pacholewicz J; Zakliczyński M; Przybyłowski P; Krauchuk A; Łowicka M; Zembala M
    Transplant Proc; 2018 Sep; 50(7):2075-2079. PubMed ID: 30177112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Morgan JA; Go PH; Xuereb L; Kaur B; Akrawe S; Nemeh HW; Borgi J; Lanfear DE; Williams CT; Paone G
    Ann Thorac Surg; 2016 Oct; 102(4):1266-73. PubMed ID: 27173072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices.
    Yost GL; Coyle L; Bhat G; Tatooles AJ
    J Artif Organs; 2016 Mar; 19(1):21-8. PubMed ID: 26187243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.
    Usoh CO; Sherazi S; Szepietowska B; Kutyifa V; McNitt S; Papernov A; Wang M; Alexis JD
    Ann Thorac Surg; 2018 Aug; 106(2):555-560. PubMed ID: 29577927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.
    Loforte A; Fiorentino M; Gliozzi G; Mariani C; Folesani G; Suarez SM; Russo A; Masetti M; Potena L; Pacini D
    Transplant Proc; 2019 Nov; 51(9):2962-2966. PubMed ID: 31607616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.
    Szyguła-Jurkiewicz B; Zakliczyński M; Szczurek W; Nadziakiewicz P; Gąsior M; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1703-7. PubMed ID: 27496475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation.
    Arai T; Yashima F; Yanagisawa R; Tanaka M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Araki M; Tada N; Yamanaka F; Shirai S; Yamamoto M; Hayashida K;
    Int J Cardiol; 2017 Feb; 228():648-653. PubMed ID: 27883976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support.
    Kawabori M; Conyer RT; Kurihara C; Sugiura T; Civitello AB; Frazier OH; Morgan JA
    Ann Thorac Surg; 2019 Apr; 107(4):1132-1138. PubMed ID: 30465757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of ventricular assist device risk scores' capacity to predict cardiopulmonary exercise parameters.
    Dorken Gallastegi A; Öztürk P; Demir E; Engin Ç; Nalbantgil S; Yağdı T; Özbaran M
    Interact Cardiovasc Thorac Surg; 2020 Feb; 30(2):223-228. PubMed ID: 31628803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation.
    Amdani S; Boyle GJ; Cantor RS; Conway J; Godown J; Kirklin JK; Koehl D; Lal AK; Law Y; Lorts A; Rosenthal DN
    J Heart Lung Transplant; 2021 Dec; 40(12):1614-1624. PubMed ID: 34598872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.